<DOC>
	<DOCNO>NCT02279186</DOCNO>
	<brief_summary>In study , efficacy safety tranexamic acid reduce blood loss elective LSCS investigate .</brief_summary>
	<brief_title>Effectiveness Intravenous Tranexamic Acid Reducing Blood Loss During After Cesarean Section</brief_title>
	<detailed_description>To state effectiveness clinically laboratory safety tranexamic acid reduce blood loss elective low segment cesarean section .</detailed_description>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Women undergo caesarean delivery various elective indication . Full term primipara / multiparas . Singleton pregnancy deliver LSCS . Medical problem involve heart , liver , kidney brain . Blood disorder . Allergy tranexamic acid . History thromboembolic disorder , abnormal placentation , severe preeclampsia , uterine anomaly pathology . Multiple pregnancy , macrosomia . Polyhydromnios . Patients require blood transfusion due anemia</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>